Newborn Screening for Hemoglobinopathies, 1st Edition
This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.
Members: $54.00 → $153.00Nonmembers: $180.00
Chairholder: Bradford L. Therrell, Jr., MS, PhD
Date of Publication: October 28, 2019
Order Code PDF: NBS08Ed1E
ISBN Number: 978-1-68440-060-7
Order Code Print: NBS08Ed1
ISBN Number: 978-1-68440-059-1
NBS08 Additional Details
A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.